Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T19:41:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior funding-status notice as well as Revision: v3.4.1. These changes appear to be maintenance updates and do not alter the trial details or patient-facing information on the page.
    Difference
    0.4%
    Check dated 2026-02-11T21:37:48.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's current status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T11:23:15.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary was added; wording tweaks include updating 'Last Update Submitted that Met QC Criteria' to proper capitalization, changing 'No FEAR Act Data' to 'No FEAR Act data', and the page footer now showing 'Revision: v3.4.0' instead of 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T09:56:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a minor revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:44:57.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A dedicated Locations section was added that lists study sites by state (Connecticut, Maryland, Massachusetts, New Jersey, New York, Pennsylvania). The previous per-state location headings were removed.
    Difference
    0.7%
    Check dated 2025-12-23T20:37:15.000Z thumbnail image

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.